Patents by Inventor Sophie Valerie Anne Ponsard

Sophie Valerie Anne Ponsard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILISED VACCINE COMPOSITION
    Publication number: 20140193481
    Abstract: A component for a HIV vaccine comprising: a) an immunogenic fusion protein comprising Nef or an immunogenic fragment or derivative thereof, and p17 Gag and/or p24 Gag or immunogenic fragments or derivatives thereof, wherein when both p17 and p24 Gag are present there is at least one HIV antigen or immunogenic fragment between them, and b) a stabilising agent selected from the group comprising or consisting of monothioglycerol, cysteine, N-acetyl cysteine or mixtures thereof. The invention also extends to HIV vaccines comprising the same and use in treatment/prevention of HIV.
    Type: Application
    Filed: November 21, 2013
    Publication date: July 10, 2014
    Applicant: GlaxoSmithKline Biologicals, s.a.
    Inventors: Dominique Ingrid LEMOINE, Sophie Valerie Anne Ponsard
  • VACCINE
    Publication number: 20100285051
    Abstract: A component for a HIV vaccine comprising: a) an immunogenic fusion protein comprising Nef or an immunogenic fragment or derivative thereof, and p17 Gag and/or p24 Gag or immunogenic fragments or derivatives thereof, wherein when both p17 and p24 Gag are present there is at least one HIV antigen or immunogenic fragment between them, and b) a stabilising agent selected from the group comprising or consisting of monothioglycerol, cysteine, N-acetyl cysteine or mixtures thereof The invention also extends to HIV vaccines comprising the same and use in treatment/prevention of HIV.
    Type: Application
    Filed: December 18, 2008
    Publication date: November 11, 2010
    Inventors: Dominique Ingrid Lemoine, Sophie Valerie Anne Ponsard